Click on the subcategory below to find drug monographs for that particular area.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
The FDA has accepted for review Santarus and Pharming's Biologics License Application for Ruconest (INN conestat alfa) 50 IU/KG, a recombinant human C1 esterase inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema.
Transfusion of red blood cells during or after surgery may increase the risk of major infections, such as pneumonia and bloodstream infections.
The first device to use Radio Frequency Identification technology to help workers track blood products and prevent the release of unsuitable samples has been approved by the U.S. Food and Drug Administration.
For patients with spontaneous intracerebral hemorrhage and elevated systolic blood pressure, intensive, rapid blood pressure lowering treatment is not associated with a significant reduction in death or severe disability at 90 days compared with guideline-recommended treatment.
Nurses need to know how to assess a patient’s risk of TLS and the treatment goals for successful management.0.75 CE for Nurses
The integration of billing procedures into medical records introduces the need for nurses to understand billing systems and medical payors.0.75 CE for Nurses
The issue of cancer care disparity is complex, as it is both a medical and a socioeconomic issue. Socioeconomic factors are the most universal contributors.0.50 CE for Nurses